Isagani Cornelio (Izzy)

Izzy Cornelio has extensive experience in the biopharmaceutical industry, with a range of roles spanning over two decades. Isagani "Izzy"'smost recent position was as the Vice President of Clinical Operations at Day One Biopharmaceuticals, where they have been since 2020. Prior to this, they worked as a Consultant at Merck from 2019 to 2020.

From 2017 to 2018, Izzy served as the Vice President of Clinical Operations at Rainier Therapeutics. Before that, they were the Executive Director of Clinical Operations at Exelixis from 2013 to 2017.

Earlier in their career, Izzy held positions such as Director of Clinical Research Operations at KaloBios Pharmaceuticals, Director of Clinical Development at Kythera Biopharmaceuticals, and Director of Medical Research at Amgen. At Amgen, they also worked as a Manager and Senior Manager. Izzy's tenure at Amgen spanned from 2000 to 2010.

Isagani "Izzy" Cornelio's education history includes attending UCLA and Cornell University. However, no information is provided regarding the specific degrees or fields of study pursued at these institutions.